This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results-
Fall 2022
Background Intraportal islet transplantation is a suitable method to treat type 1 diabetes. However, this treatment option is limited to a small subpopulation of patients with diabetes. For islet transplantation to be a more sustainable treatment option, major obstacles must be overcome. An...
-
Diagnostic Applications of Microarrays and Gene Expression in Transplants and Native Organs
DownloadFall 2020
There is a major unmet need for improved accuracy and precision in the diagnoses of transplant rejection and diseases causing tissue injury. Diagnoses relying on histologic assessments and visual assessments demonstrate significant variation between expert observers (as represented by low kappa...
-
Fall 2023
Normothermic machine perfusion (NMP) is a novel method of organ preservation that has recently risen in prominence. NMP involves the maintenance of an organ outside the body to recreate its physiologic milieu, such as by providing oxygen and nutrients and maintaining temperature. We are only just...
-
Fall 2022
Marfil Garza, Braulio Alejandro
Type 1 diabetes (T1D) is caused by autoimmune-mediated destruction of the insulin-producing β-cells in the pancreatic islets of Langerhans. People with T1D need exogenous insulin to survive, but also to avoid complications from uncontrolled glycemia. Unfortunately, insulin treatment commonly...
-
Fall 2018
Type 1 diabetes mellitus (T1DM) is characterized by the autoimmune destruction of insulin-producing beta (β)-cells within pancreatic islets of Langerhans. For many patients, frequent blood glucose monitoring and insulin administration are primary therapies aimed to curb hyperglycemia, though...